# Digoxin

Digoxin is a cardiac glycoside used in the treat of atrial arrhythmias and in cardiac failure as a positive inotrope.

It has a direct and indirect **mechanism of action**:
* Inhibits cardiac Na<sup>+</sup>/K<sup>+</sup> ATPase increasing intracellular [Na<sup>+</sup>], causing increased exchange with extracellular Ca<sup>2+</sup>. Increased intracellular Ca<sup>2+</sup> results in increased inotropy, whilst decreased K<sup>+</sup> results in a prolonged refractory period of the AV node and bundle of His.
* Parasympathomimetic effects by increasing ACh release at cardiac muscarinic receptors, which slows AV nodal conduction and ventricular response. This improves coronary blood flow and gives greater time for ventricular filling, resulting in an improvement in cardiac output.

|Property|Action|
|--|--|
|**Class**|Cardiac Glycoside|
|**Uses**|Arrhythmia - particularly AF/Flutter, and CCF|
|**Presentation**|Tablets, elixir, clear colourless solution at
|**Route of Administration**|PO/IV|
|**Dosing**|PO: 62.5μg-250μg, IV: 250-500μg load|
|**Absorption**|>70% bioavailability though varies with formulation|
|**Distribution**|25% protein bound. V<sub>D</sub> 5-11L.kg<sup>-1</sup>, dependent on lean mass|
|**Metabolism**|Minimal hepatic metabolism|
|**Elimination**|Renal elimination of active metabolites t<sub>1/2</sub> 35 hours - increased in renal failure|
|**CVS**|↓ HR, ↑ inotropy, arrhythmia, bigemini, PVCs, 1<sup>st</sup>/2<sup>nd</sup>/3<sup>rd</sup> degree AV block, SVT, VT
|**CNS**|Deranged red-green colour perception, visual disturbances, headache|
|**Immune**|Eosinophilia and rash
|**Metabolic**|Gynaecomastia
|**Toxic Effects**|Narrow TI. Severe arrhythmia with DC cardioversion

###Interactions
|Interaction|Drug|
|--|--|
|**Increased level**|Amiodarone, captopril erythromycin, carbenoxolone, verapamil|
|**Decreased level**|Antacids, cholestyramine, phneytoin, metoclopramide|

##References
Peck and Hill